Enabling precision medicine
Olink Proteomics at a glance
Olink develops and markets its unique technology for protein analysis in human protein biomarker research. Olink’s proprietary Proximity Extension Assay (PEA) technology enables researchers to analyze large numbers of proteins with high-throughput analysis, exceptional data quality, and minimal sample consumption. This enables research which previously could not be done and lowers costs. The technology drives precision medicine by improving the understanding of the interaction of proteins and human disease.
Year acquired
Sector
Location
Employees
Website
Investment themes
Contact
Impact dimensions
The challenges we face
We currently suffer from ineffective medication due to a lack of understanding of the biology of diseases. The shift from the "one size fits all" approach to precision medicine is a colossal challenge for science. Delivering the right treatment, to the right patient at the appropriate time requires developing protein biomarker panels to improve our understanding of human biology and optimize the development of new drugs and treatments.
is the expected proportion of people aged 80 or above in the year 2070, up from 4.9% in 2016.
share of GDP spent on healthcare in the OECD
What is the outcome?
Olink contributes to the understanding of the human biology through its unique technology aimed at science related to proteomics. Olink’s approach enables science that was not previously possible, and is a key contributor to precision medicine.
Who are the stakeholders?
Olink's customers are primarily found in pharma and in academic centers.
How big is the effect, and does it last?
Olink, with a library of over 2 947 validated biomarker assays, has been mentioned in 791 publications, supporting protein biomarker discovery research globally. Enabling precision medicine is important to drive better patient outcomes and sustainable costs in healthcare systems over time.
If Olink Proteomics didn’t exist...
Since Olink provides a truly unique technology to the market, it makes a great contribution to precision medicine. If Olink did not exist, a vast majority of the research that it enables would not get done.
Impact risk: what can go wrong?
Product quality is fundamentally important, so if Olink would be unable to deliver strong product quality, its customers would likely stop using its products.
SDG alignments
